The Multi-state operator Cresco Labs is set to expand its presence in the US with an initial agreement for a Florida-based operation. On Monday, March 18th, 2020, the company confirmed its pursuit of the medical-only market in Florida, which is projected to reach a value of US$1.7 billion in 2022 according to the Arcview Market Research and BDS Analytics. Now, Cresco announced that the shares will be part of a lock-up that can last between six and 12 months because the acquisition of VidaCann will cost Cresco Labs approximately $120 million.

– Hemp Land, Cannabis Hemp Blog, 08/10/2020 1:07:56 AM

Open article: